| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |